Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.

BBC readers shared opinions on crying at work, with experts discussing emotional intelligence in the workplace and how tears may be perceived differently based on gender and seniority.

The New York Times revealed the mixed opinions amongst Democratic strategists over Project 2029, which aims to create a cohesive agenda for future Democratic presidential candidates.

A new migrant detention site in Collier County, known as "Alligator Alcatraz," is causing a stir among locals.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2025 that were previously approved by the Compensation ...

The latest charts from “Morning Joe” economic analyst Steve Rattner are in, and the new data could signal trouble ahead for Donald Trump’s economy. On Thursday morning, Rattner, a former ...

After Gov. Ron DeSantis named Camp Blanding Joint Training Center an Immigration and Customs Enforcement (ICE) detention facility, a few residents sounded off about the possible new addition.

In the preceding three months, 38 analysts have released ratings for Sarepta Therapeutics SRPT, presenting a wide array of perspectives from bullish to bearish. The table below provides a concise ...

But, the potential reopening is still garnering divided opinions from the public. Ken Priest was just one of the community members to come to the event, and supports the reopening.

A yearslong effort to reopen a nuclear power plant in Van Buren County is now nearing the finish line.

FDA evaluating further regulatory actions after deaths Elevidys is the only gene therapy for Duchenne muscular dystrophy Sarepta suggested updating Elevidys' label June 24 (Reuters) - The U.S ...

In a market note, Oppenheimer significantly lowered its price target for Sarepta Therapeutics, Inc. (NASDAQ:SRPT) to $45 from $123 previously, marking a 63-percent downside.